ALZ-NET International Case Study Series: Exploring Eligibility

Join us for the first episode of Series 1 of the ALZ-NET International Case Study Series, which will explore eligibility of patients for treatment.

Two cases will be discussed in Episode 1.

Case #1: 89 yo M with amnestic MCI, amyloid positive, functionally intact and very interested in lecanemab. Should he get lecanemab even though he is outside the age of 85? How do we balance the risk of LATE with AD in patients in their late 80s?
Case #2: 69 yo F with hyperlipidemia and diagnosis of mild dementia due to suspected AD (biomarker testing revealed positive amyloid PET).

Presenters: Charles Windon, Mia Yang
Panelists: Hal Atkinson, Marc Benayoun
Moderator: Tammie Benzinger